Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 208
Selected: 0
NCT IDTitle
NCT06234397Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
NCT01929070A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007
NCT03479073Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation
NCT04076293Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912(Sonefpeglutide) in Healthy Korean Subjects
NCT05555238An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia
NCT04975711Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers
NCT04204629Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects
NCT00979563Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies
NCT01491503A Drug Interaction Study of Montelukast and Levocetirizine
NCT01688193Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male
NCT02239484Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin
NCT02011633Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg
NCT02390882A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH
NCT00940680Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension
NCT02075281Effect of LAPS-Exendin on Body Weight in Obese Population
NCT03713684Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)
NCT07899073A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction Patients
NCT05723549A Study to Evaluate the PK, Safety and Tolerability of HCP1803.
NCT01872182Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
NCT03684642Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
NCT01651481Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination
NCT02057172Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
NCT05155995A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers
NCT05862090A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers
NCT03744182A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD
NCT04324905Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers
NCT02545829Evaluating the Bioequivalence of HIP1302, HGP1406
NCT01724814A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
NCT05481307A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203
NCT01447797A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin
NCT07660796A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension
NCT06174766A Study to Evaluate Efficacy and Safety of HGP2304 in Essential Hypertension Patients
NCT04087525A Study to Evaluate the Pharmacokinetics and Safety of HIP1701 in Healthy Subjects
NCT01127217Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension
NCT03897868A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
NCT02941848Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers
NCT01448330A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin
NCT03284502HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors
NCT02127320Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe
NCT01638286Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects
NCT06357910A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
NCT01913847Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
NCT04967014Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers
NCT01822340Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients
NCT01442987Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia
NCT04081844A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.
NCT04775706Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
NCT02418689Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens
NCT02940314Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers
NCT01819428NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma